POLYNEUROPATHY, INFLAMMATORY DEMYELINATING, CHRONIC

Clinical trials for POLYNEUROPATHY, INFLAMMATORY DEMYELINATING, CHRONIC explained in plain language.

Never miss a new study

Get alerted when new POLYNEUROPATHY, INFLAMMATORY DEMYELINATING, CHRONIC trials appear

Sign up with your email to follow new studies for POLYNEUROPATHY, INFLAMMATORY DEMYELINATING, CHRONIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

Four-Year quest for safer nerve disease control

Disease control ENROLLING_BY_INVITATION

This study aims to understand the long-term safety and effectiveness of the drug riliprubart for adults with chronic inflammatory demyelinating polyneuropathy (CIDP), a nerve disorder. About 300 participants who have already been taking riliprubart in earlier studies can continue…

Matched conditions: POLYNEUROPATHY, INFLAMMATORY DEMYELINATING, CHRONIC

Phase: PHASE3 • Sponsor: Sanofi • Aim: Disease control

Last updated Mar 23, 2026 15:18 UTC

POLYNEUROPATHY, INFLAMMATORY DEMYELINATING, CHRONIC

Get alerted when new POLYNEUROPATHY, INFLAMMATORY DEMYELINATING, CHRONIC trials appear

Four-Year quest for safer nerve disease control